Halozyme Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $579.9M
Liabilities Breakdown FY2020
Total Liabilities: $428.9M
Asset Breakdown
Total Assets: $579.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $147.7M | 25.5% |
| Accounts Receivable | $97.7M | 16.9% |
| Inventory | $60.7M | 10.5% |
| Property, Plant & Equipment | $7.3M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $266.5M | 45.9% |
Liabilities Breakdown
Total Liabilities: $428.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 0.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $426.9M | 99.6% |